Whitehawk Therapeutics (WHWK) Total Liabilities (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Total Liabilities of $11.1 million for Q1 2026, down 9.92% year-over-year from $12.3 million in Q1 2025, and down 23.85% quarter-over-quarter from $14.5 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Total Liabilities (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Total Liabilities for 17 consecutive years, with $11.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 9.92% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $11.1 million (down 9.92% YoY), while the FY2025 annual figure was $14.5 million, down 18.62% from the prior year.
- Total Liabilities retreated to $11.1 million in Q1 2026 per WHWK's latest filing, from $14.5 million in the prior quarter.
- Across five years, Total Liabilities topped out at $27.2 million in Q4 2023 and bottomed at $8.8 million in Q2 2025.
- Historically, Total Liabilities has averaged $18.6 million across 5 years, with a median of $19.8 million in 2023.
- Annual changes were most pronounced in 2022 — Total Liabilities soared 801.5% — and 2025, when it slumped 61.65%.
- Whitehawk Therapeutics' Total Liabilities stood at $25.9 million in 2022, then rose by 5.29% to $27.2 million in 2023, then slumped by 34.48% to $17.8 million in 2024, then retreated by 18.62% to $14.5 million in 2025, then decreased by 23.85% to $11.1 million in 2026.
- Business Quant data shows WHWK's Total Liabilities at $11.1 million in Q1 2026, $14.5 million in Q4 2025, and $9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | 11.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.07 Mn |
| Mar 31, 2026 | 11.06 Mn |
| Dec 31, 2025 | 14.52 Mn |
| Sep 30, 2025 | 9.85 Mn |
| Jun 30, 2025 | 8.76 Mn |
| Mar 31, 2025 | 12.27 Mn |
| Dec 31, 2024 | 17.84 Mn |
| Sep 30, 2024 | 16.83 Mn |
| Jun 30, 2024 | 22.83 Mn |
| Mar 31, 2024 | 20.61 Mn |
| Dec 31, 2023 | 27.23 Mn |
| Sep 30, 2023 | 21.46 Mn |
| Jun 30, 2023 | 19.81 Mn |
| Mar 31, 2023 | 24.67 Mn |
| Dec 31, 2022 | 25.86 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Jun 30, 2022 | 19.91 Mn |
| Mar 31, 2022 | 17.69 Mn |
| Dec 31, 2021 | 21.50 Mn |
| Sep 30, 2021 | 17.85 Mn |